Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Capital Expenditures: 2011-2024

Historic Capital Expenditures for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to $163,000.

  • Niagen Bioscience's Capital Expenditures fell 41.46% to $24,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $260,000, marking a year-over-year increase of 126.09%. This contributed to the annual value of $163,000 for FY2024, which is 10.14% up from last year.
  • According to the latest figures from FY2024, Niagen Bioscience's Capital Expenditures is $163,000, which was up 10.14% from $148,000 recorded in FY2023.
  • Niagen Bioscience's 5-year Capital Expenditures high stood at $409,000 for FY2021, and its period low was $124,000 during FY2020.
  • For the 3-year period, Niagen Bioscience's Capital Expenditures averaged around $215,000, with its median value being $163,000 (2024).
  • Its Capital Expenditures has fluctuated over the past 5 years, first crashed by 83.31% in 2020, then soared by 229.84% in 2021.
  • Yearly analysis of 5 years shows Niagen Bioscience's Capital Expenditures stood at $124,000 in 2020, then soared by 229.84% to $409,000 in 2021, then decreased by 18.34% to $334,000 in 2022, then plummeted by 55.69% to $148,000 in 2023, then increased by 10.14% to $163,000 in 2024.